News

Clinical Trials Arena7h

BlossomHill doses first patient in SOLARA study’s expansion cohorts

BlossomHill Therapeutics has dosed the first subject in the expansion cohorts of the SOLARA Phase I/II trial to evaluate ...
Clinical Trials Arena9h

Lighthouse secures $49.2m NIA grant for Alzheimer’s therapy trial

Lighthouse secured a grant of $49.2m from the National Institute on Aging (NIA) to facilitate study of LHP588 for Alzheimer's ...